Article
Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
Clinical endocrinology - 1 May 2013
Park So Young, Mun Hee-Chang, Eom Young Sil, Baek Hae Lim, Jung Tae Sik, Kim Chul Hoon, Hong Suntaek, Lee Sihoon
Abstract excerpt
OBJECTIVE: Activating mutations of the calcium-sensing receptor (CASR) gene are associated with autosomal dominant hypocalcemia (ADH) characterized by benign hypocalcemia, inappropriately low (PTH) levels and mostly hypercalciuria. Herein, we report a novel activating mutation in the CASR gene in a Korean family with ADH. METHOD: The CASR gene was sequenced in the patient with ADH. The identified mutations were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
